dc.contributor.author | Du, Yong | de |
dc.contributor.author | Baumert, Jens | de |
dc.contributor.author | Damerow, Stefan | de |
dc.contributor.author | Rommel, Alexander | de |
dc.contributor.author | Scheidt-Nave, Christa | de |
dc.contributor.author | Heidemann, Christin | de |
dc.date.accessioned | 2022-02-28T15:26:06Z | |
dc.date.available | 2022-02-28T15:26:06Z | |
dc.date.issued | 2021 | de |
dc.identifier.issn | 2511-2708 | de |
dc.identifier.uri | https://www.ssoar.info/ssoar/handle/document/77764 | |
dc.description.abstract | People with diabetes regularly need outpatient medical care due to their disease and possible concomitant and secondary illnesses. Using data from the nationwide GEDA 2019/2020-EHIS survey conducted from April 2019 to September 2020, the present study examines developments in outpatient utilisation behaviour during the measures put in place to contain the SARS-CoV-2 pandemic. During the observation period, people with diabetes had a significantly higher rate of utilisation of medical services provided by general practitioners (GPs) and specialists than the population as a whole. In the spring of 2020, when the restrictions were put in place, utilisation of specialist medical services by people with diabetes decreased temporarily by 46% compared to the 2019 reference period. In contrast, no relevant decline in the utilisation of medical services provided by GPs was observed, but this could be related to adaptations of care provision through telephone consultations for people with regularly requiring GP office visits. The issue examined here requires further observations in view of the renewed containment measures. | de |
dc.language | en | de |
dc.subject.ddc | Sozialwissenschaften, Soziologie | de |
dc.subject.ddc | Social sciences, sociology, anthropology | en |
dc.subject.other | medical services; diabetes; SARS-COV-2; COVID-19; GEDA 2019/2020-EHIS; 2018 microcensus | de |
dc.title | Utilisation of outpatient medical services by people with diagnosed diabetes during the COVID-19 pandemic in Germany | de |
dc.title.alternative | Inanspruchnahme ambulanter ärztlicher Leistungen während der COVID-19-Pandemie bei Menschen mit Diabetes in Deutschland | de |
dc.description.review | begutachtet (peer reviewed) | de |
dc.description.review | peer reviewed | en |
dc.source.journal | Journal of Health Monitoring | |
dc.source.volume | 6 | de |
dc.publisher.country | DEU | de |
dc.source.issue | 2 | de |
dc.subject.classoz | Gesundheitspolitik | de |
dc.subject.classoz | Health Policy | en |
dc.subject.thesoz | Inanspruchnahme | de |
dc.subject.thesoz | recourse | en |
dc.subject.thesoz | Gesundheitsleistung | de |
dc.subject.thesoz | health service | en |
dc.subject.thesoz | chronische Krankheit | de |
dc.subject.thesoz | chronic illness | en |
dc.subject.thesoz | Epidemie | de |
dc.subject.thesoz | epidemic | en |
dc.subject.thesoz | ambulante Behandlung | de |
dc.subject.thesoz | outpatient treatment | en |
dc.subject.thesoz | ambulante Versorgung | de |
dc.subject.thesoz | outpatient care | en |
dc.subject.thesoz | Gesundheitsversorgung | de |
dc.subject.thesoz | health care | en |
dc.subject.thesoz | medizinische Versorgung | de |
dc.subject.thesoz | medical care | en |
dc.subject.thesoz | Indikator | de |
dc.subject.thesoz | indicator | en |
dc.subject.thesoz | Bundesrepublik Deutschland | de |
dc.subject.thesoz | Federal Republic of Germany | en |
dc.identifier.urn | urn:nbn:de:0168-ssoar-77764-5 | |
dc.rights.licence | Creative Commons - Namensnennung 4.0 | de |
dc.rights.licence | Creative Commons - Attribution 4.0 | en |
ssoar.contributor.institution | FDB | de |
internal.status | formal und inhaltlich fertig erschlossen | de |
internal.identifier.thesoz | 10047100 | |
internal.identifier.thesoz | 10079581 | |
internal.identifier.thesoz | 10040302 | |
internal.identifier.thesoz | 10042424 | |
internal.identifier.thesoz | 10035396 | |
internal.identifier.thesoz | 10035400 | |
internal.identifier.thesoz | 10045504 | |
internal.identifier.thesoz | 10034647 | |
internal.identifier.thesoz | 10047129 | |
internal.identifier.thesoz | 10037571 | |
dc.type.stock | article | de |
dc.type.document | Zeitschriftenartikel | de |
dc.type.document | journal article | en |
dc.source.pageinfo | 51-58 | de |
internal.identifier.classoz | 11006 | |
internal.identifier.journal | 1954 | |
internal.identifier.document | 32 | |
internal.identifier.ddc | 300 | |
dc.source.issuetopic | Diabetes surveillance in Germany: New results within the context of diabetes care and the COVID-19 pandemic | de |
dc.identifier.doi | https://doi.org/10.25646/8333 | de |
dc.description.pubstatus | Veröffentlichungsversion | de |
dc.description.pubstatus | Published Version | en |
internal.identifier.licence | 16 | |
internal.identifier.pubstatus | 1 | |
internal.identifier.review | 1 | |
dc.subject.classhort | 11000 | de |
internal.pdf.wellformed | true | |
internal.pdf.encrypted | false | |